Skip to content

Evaluation of cholesterol lowering efficacy of Rice bran oil, Olive oil and Groundnut oil

A Comparative Evaluation of Anti-hyperlipidemic efficacy of Rice bran oil, Olive oil and Groundnut oil: A Clinical Investigation in individuals with hypercholesterolemia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/02/003365
Enrollment
120
Registered
2013-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with LDL levels more than 130 mg/dL of plasma

Interventions

Intervention1: 1. Rice Bran oil 2. Olive Oil 3. Ground Nut oil: Eligible subjects willing to participate in the study will be randomized to receive either of the 3 cooking oils for the entire family r

Sponsors

AP ORGANICS PVT LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex 2. Age > 25 years and 3. Patients with LDL cholesterol of >130 mg % with (receiving equivalent doses of statins) or without lipid lowering therapy 4. Willing to consent 5. Number of adult family members

Exclusion criteria

Exclusion criteria: 1. BMI >30 kg/m2 2. Patients consuming laxatives for more than twice a month 3. Consuming more >20g alcohol per day and more than 10 cigarettes per day 4. Lactating or pregnant mothers 5. Regular users of rice bran oil, olive oil or groundnut oil for last 3 months 6. Those who take more than 2 meals per week outside home or frequent travelers

Design outcomes

Primary

MeasureTime frame
Change in LDL-Cholesterol levels following 3 months of regular use of either of the study oilsTimepoint: Change in LDL-Cholesterol levels following every month for 3 months of regular use of either of the study oil

Secondary

MeasureTime frame
Possible changes in: 1. Body weight 2. Fasting blood glucose levels 3. lipid profile (HDL, VLDL and Total cholesterol and triglycerides) Timepoint: every month for 3 consecutive months

Countries

India

Contacts

Public ContactDr Debasish Hota

Post graduate Institute of Medical Education and Research

debhota@gmail.com9417430881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026